Taiwanese Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Shine-On BioMedicalLtd

Market Cap: NT$3.7b

Research, develops, and manufactures anti-cancer related drug products.

CHO Pharma

Market Cap: NT$8.2b

Engages in research and development of biotechnology in Taiwan.

BIONET Therapeutics

Market Cap: NT$4.0b

A biopharmaceutical company, develops cell therapy products and drug development for acute and severe diseases.

Intelligene

Market Cap: NT$5.6b

Engages in the development of RNA gene therapy drugs for infectious diseases.

Sunhawk Vision Biotech

Market Cap: NT$5.2b

Operates as a drug development company that develops microRNA therapeutic eye drops.

PharmaEngine

Market Cap: NT$9.7b

A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.

HeXun Biosciences

Market Cap: NT$2.9b

Engages in the research and development of stem cell and treatments in Taiwan.

Synmosa Biopharma

Market Cap: NT$15.8b

A specialty pharmaceutical company, researches, develops, manufactures, markets, and distributes pharmaceutical and healthcare products under the Synmosa brand in Taiwan.

TCM Biotech International

Market Cap: NT$6.9b

A biotech company, engages in the research and development of drugs for liver diseases.

EirGenix

Market Cap: NT$19.0b

Operates as a contract development and manufacturing company in Taiwan and internationally.

Bonraybio

Market Cap: NT$4.2b

A development stage company, manufactures medical instruments and solutions for the male infertility market.

Orient Pharma

Market Cap: NT$5.7b

Engages in the research and development, manufacturing, and sales of drugs in Taiwan and internationally.

Advagene Biopharma

Market Cap: NT$2.1b

Engages in the research and development of vaccine technology and related products in Taiwan.

Holy Stone Healthcare

Market Cap: NT$1.5b

Develops and sells hyaluronic acid related therapeutic products.

Anya Biopharm

Market Cap: NT$2.3b

A pharmaceutical company, develops platform for oral peptides.

PhytoHealth

Market Cap: NT$3.1b

Researches and develops, manufactures, and sells pharmaceutical drugs, cosmetics, Class B medicines, and dietary supplements in Taiwan.

Savior Lifetec

Market Cap: NT$5.7b

A specialty injectable company, develops, produces, and supplies sterile active pharmaceutical ingredients and finished dosage formulations.

Eusol BiotechLtd

Market Cap: NT$1.0b

Focuses on research and development of new biotech drugs for sleep disorders.

Maxigen Biotech

Market Cap: NT$3.7b

Researches, develops, produces, and sells implantable medical devices and cosmetic products in Taiwan, America, Europe, rest of Asia, and internationally.

StemCyte International

Market Cap: NT$4.7b

Operates cord blood cell banks in the United States and Taiwan.

Formosa Pharmaceuticals

Market Cap: NT$4.6b

A clinical stage biopharmaceutical company, engages in developing drug candidates for ophthalmology, oncology, and anti-infectives in Taiwan.

Oneness Biotech

Market Cap: NT$31.8b

Engages in the research, development, and sale of new drugs, pharmaceuticals, and health products primarily in Taiwan.

TaiwanJ Pharmaceuticals

Market Cap: NT$642.6m

A specialty pharmaceutical company, develops and commercializes small molecules for chronic organ inflammation of metabolic, autoimmune, and infectious etiologies in Taiwan.

Alar Pharmaceuticals

Market Cap: NT$14.5b

A drug development company, focuses on developing long-acting release drug products for CNS disorders and chronic diseases in Taiwan.

ScinoPharm Taiwan

Market Cap: NT$15.2b

Research and develops, produces, and sells active pharmaceutical ingredients (API) to pharmaceutical companies in Taiwan, rest of Asia, Europe, India, the United States and internationally.

Ever Supreme Bio Technology

Market Cap: NT$15.6b

Engages in the research, development, and manufacture of drug products related to human mesenchymal stem cells and immune cells in Taiwan.

Sinew Pharma

Market Cap: NT$3.4b

A biopharmaceutical company, focuses on the development and sale of drugs for the treatment of hepatotoxicity-free acetaminophen and fatty liver diseases.

Pharmosa Biopharm

Market Cap: NT$6.0b

A biotechnology company, focuses on developing drugs in Taiwan.

Senhwa Biosciences

Market Cap: NT$3.6b

A drug development company, engages in the development of new drugs and targeted agents.

Standard Chemical & Pharmaceutical

Market Cap: NT$10.1b

Standard Chemical & Pharmaceutical Co. Ltd.

Genetics Generation Advancement

Market Cap: NT$1.5b

Provides genetic testing and informatics services in Taiwan.

ACRO Biomedical

Market Cap: NT$4.5b

Develops medical-grade regenerative biomaterials.

TWi Biotechnology

Market Cap: NT$3.5b

A clinical-stage biopharmaceutical company, develops and sells drugs for innate immunity-related diseases in Taiwan.

Vectorite Biomedical

Market Cap: NT$612.8m

Engages in the research and development of biotechnology in Taiwan and internationally.

TaiRx

Market Cap: NT$3.1b

Focuses on the development and commercialization of therapeutics for the treatment of cancer and other diseases.

BRIM Biotechnology

Market Cap: NT$4.2b

A clinical-stage company, engages in the development of novel regenerative therapies to combat and cure ophthalmology and degenerative joint diseases.